News
Trial follow-up spotlights survival gains in follicular lymphoma
The 13-year update to the GITMO-IIL trial showed the important role of complete remission in prolonged survival. This is the longest follow-up...
News
FDA approves venetoclax/obinutuzumab combo for CLL
Venetoclax/obinutuzumab was compared with venetoclax/chlorambucil in the CLL14 study and showed superior progression-free survival in previously...
News
Short telomeres predict poorer response to chemo in CLL
High-throughput, single telomere–length analysis appears to be a useful tool in predicting response to FCR-based treatment among previously...
News
Bendamustine-rituximab shines in frontline treatment of MCL, iNHL
Long-term follow-up data from the BRIGHT study support bendamustine plus rituximab as a frontline treatment option in mantle cell lymphoma and...
News
Turoctocog alfa appears safe, effective in reducing bleeds
The phase 3b open label trial included extended use of turoctocog alfa among males of all ages with severe hemophilia A.
News
Thrombin generation looks promising as a hemophilia biomarker
SAN DIEGO – Thrombin generation appears better able to differentiate between bleeding severities, compared with baseline factor activity.
News
Study identifies four patient subgroups in hemophilia A
SAN DIEGO – The Hemophilia Inhibitor PUP Study (HIPS) analyzed Factor VIII–specific antibodies in previously untreated infants with severe...
News
Myeloma expert named as endowed cancer chair at Emory
News on Dr. Sagar Lonial, Dr. J. Ross Mitchell, Dr. Oren Cahlon, and the death of Dr. Bertrand Coiffier.
News
RNA expression may hold key to hemophilia A severity
Expression of two long noncoding RNAs on the factor VIII gene was lower in patients with severe hemophilia A.
News
Study supports need for less toxic therapies in FL
The study examines causes of death for follicular lymphoma patients in the rituximab era.
News
Baselga moves to industry; MD Anderson mourns
Movers in Medicine highlights career moves and personal achievements by physicians in the hematology and oncology fields.
News
Sickle cell infusion gains FDA breakthrough designation
The investigational therapy is aimed at preventing vasoocclusive crises.
Video
CLL at ASH: A ‘mountain of data’ for targeted therapies
SAN DIEGO – Dr. Brian Hill and Dr. Anthony Mato break down the take-home points from the key studies on chronic lymphocytic leukemia presented at...
Video
Social media can help doctors stay up to date
SAN DIEGO – Dr. Amber Yates said being active on Twitter has helped her streamline the journals she reads.
Video
LCAR-B38M CAR T therapy appears durable in myeloma
SAN DIEGO – Positive phase 1 results keep LCAR-B38M in the CAR T race in multiple myeloma.